Optimi Health Corp.

Update in progress

OPTH (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Optimi Health Corp. is a Canadian pharmaceutical and nutraceutical company focused on psychedelic and botanical products. It manufactures controlled substances, including finished MDMA and psilocybin products, for licensed clinics, pharmacies, trials, and partners. The company develops natural psilocybin, psilocin, other psychedelics, and functional mushrooms from botanical sources for health and wellness. It farms, processes, and distributes mushroom biomass, extracts, and supplements, sold online and via distributors. Based in Princeton, incorporated 2020.

Company score

Sentiment: 0.49; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.42; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.17; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.16; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.32; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive